Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holmfridur Helgadottir

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Gastroenterology|February 23, 2023
Noninvasive evaluation of fibrosis in adult biliary diseasesHolmfridur Helgadottir, Mette Vesterhus
International Journal of Molecular Sciences|November 6, 2019
Problems Associated with Deprescribing of Proton Pump InhibitorsHolmfridur Helgadottir, Einar S Bjornsson
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
The Impact of Sex on the Response to Proton Pump Inhibitor TreatmentHolmfridur Helgadottir, Einar S Björnsson
Laeknabladid|June 28, 2023
[Current use of proton pump inhibitors and when to limit, stop or not start treatment]Holmfridur Helgadottir, Einar Stefan Bjornsson
Scandinavian Journal of Gastroenterology|November 12, 2022
Improvement of cholestatic episodes in patients with benign recurrent intrahepatic cholestasis (BRIC) treated with rifampicin. A long-term follow-upHolmfridur Helgadottir, Geir Folvik, Mette Vesterhus
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 21, 2023
[Primary sclerosing cholangitis]Holmfridur Helgadottir, Trine Folseraas, Gunter Kemmerich, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Gastroenterology|February 23, 2023
Noninvasive evaluation of fibrosis in adult biliary diseasesHolmfridur Helgadottir, Mette Vesterhus
International Journal of Molecular Sciences|November 6, 2019
Problems Associated with Deprescribing of Proton Pump InhibitorsHolmfridur Helgadottir, Einar S Bjornsson
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
The Impact of Sex on the Response to Proton Pump Inhibitor TreatmentHolmfridur Helgadottir, Einar S Björnsson
Laeknabladid|June 28, 2023
[Current use of proton pump inhibitors and when to limit, stop or not start treatment]Holmfridur Helgadottir, Einar Stefan Bjornsson
Scandinavian Journal of Gastroenterology|November 12, 2022
Improvement of cholestatic episodes in patients with benign recurrent intrahepatic cholestasis (BRIC) treated with rifampicin. A long-term follow-upHolmfridur Helgadottir, Geir Folvik, Mette Vesterhus
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 21, 2023
[Primary sclerosing cholangitis]Holmfridur Helgadottir, Trine Folseraas, Gunter Kemmerich, et al.
Pageof 1